meglumine and Coma

meglumine has been researched along with Coma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batotsyrenov, BV; Batotsyrenova, KhV; Livanov, GA; Lodiagin, AN; Shestova, GV1
Batotsyrenov, BV; Batotsyrenova, KhV; Bazarova, VG; Glushkov, SI; Livanov, GA; Vasil'ev, SA1
Batotsyrenov, KhV; Bazarova, VG; Livanov, GA; Shestova, GV; Tsvetnova, LD; Velikova, VD1

Trials

1 trial(s) available for meglumine and Coma

ArticleYear
[Mechanism of neuroprotector action of metabolic antihypoxant reamberin in patients with toxicohypoxic encephalopathy].
    Eksperimental'naia i klinicheskaia farmakologiia, 2012, Volume: 75, Issue:1

    Topics: Adult; Antioxidants; Autoantibodies; Coma; Delirium; Female; Humans; Hypoxia, Brain; Lipid Peroxidation; Male; Meglumine; Neurotoxicity Syndromes; Succinates

2012

Other Studies

2 other study(ies) available for meglumine and Coma

ArticleYear
[Correction of tissue hypoxia with reamberin in severe forms of acute intoxication with neurotropic poisons].
    Klinicheskaia meditsina, 2010, Volume: 88, Issue:5

    Topics: Adult; Antioxidants; Coma; Humans; Hypoxia; Male; Meglumine; Neurotoxicity Syndromes; Succinates

2010
[Neuroprotective effects of succinate-containing antihypoxante reamberine in treatment of patients with toxicohypoxic brain injury].
    Georgian medical news, 2012, Issue:205

    Topics: Adult; Antioxidants; Brain Injuries; Coma; Female; Humans; Lipid Peroxidation; Male; Meglumine; Neuroprotective Agents; Neurotoxicity Syndromes; Poisoning; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Succinates

2012